Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic management of malignant biliary obstructions.
Binda C, Trebbi M, Coluccio C, Giuffrida P, Perini B, Gibiino G, Fabbri S, Liverani E, Fabbri C. Binda C, et al. Among authors: giuffrida p. Ann Gastroenterol. 2024 May-Jun;37(3):291-302. doi: 10.20524/aog.2024.0883. Epub 2024 Apr 29. Ann Gastroenterol. 2024. PMID: 38779637 Free PMC article. Review.
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
Pelizzaro F, Trevisani F, Simeon V, Vitale A, Cillo U, Piscaglia F, Missale G, Sangiovanni A, Foschi FG, Cabibbo G, Caturelli E, Di Marco M, Azzaroli F, Brunetto MR, Raimondo G, Vidili G, Guarino M, Gasbarrini A, Campani C, Svegliati-Baroni G, Giannini EG, Mega A, Masotto A, Rapaccini GL, Magalotti D, Sacco R, Nardone G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Pelizzaro F, et al. Liver Int. 2023 Dec;43(12):2762-2775. doi: 10.1111/liv.15719. Epub 2023 Sep 27. Liver Int. 2023. PMID: 37753540
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints.
Giuffrida P, Celsa C, Antonucci M, Peri M, Grassini MV, Rancatore G, Giacchetto CM, Cannella R, Incorvaia L, Corsini LR, Morana P, La Mantia C, Badalamenti G, Brancatelli G, Cammà C, Cabibbo G. Giuffrida P, et al. Biomedicines. 2022 Nov 6;10(11):2827. doi: 10.3390/biomedicines10112827. Biomedicines. 2022. PMID: 36359347 Free PMC article. Review.
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.
Giannini EG, Pasta A, Pieri G, Plaz Torres MC, Marseglia M, Pelizzaro F, Sangiovanni A, Cabibbo G, Ghittoni G, Di Marco M, Foschi FG, Guarino M, Biasini E, Saitta C, Campani C, Svegliati-Baroni G, Gasbarrini A, Brunetto MR, Magalotti D, Azzaroli F, Mega A, Sacco R, Nardone G, Sacerdoti D, Masotto A, Vidili G, Bucci L, Vitale A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Giannini EG, et al. Liver Int. 2024 Jul;44(7):1588-1599. doi: 10.1111/liv.15855. Epub 2024 Mar 1. Liver Int. 2024. PMID: 38426262
Systemic therapies for hepatocellular carcinoma: the present and the future.
Celsa C, Giuffrida P, Stornello C, Grova M, Spatola F, Rizzo GEM, Busacca A, Cannella R, Battaglia S, Cammà C, Cabibbo G. Celsa C, et al. Among authors: giuffrida p. Recenti Prog Med. 2021 Feb;112(2):110-116. doi: 10.1701/3559.35371. Recenti Prog Med. 2021. PMID: 33624623 Review.
102 results